Sep 14, 2021 / 07:30PM GMT
Joseph Modisett -
Good afternoon, everyone. My name is Joe Modisett. I lead our health care investment banking effort in the U.S. It's great today that we have Elanco with us. We have Jeff Simmons, President and CEO. And before we jump into Q&A, I'm going to read some of the standard disclosures here. So for important disclosures, please see the Morgan Stanley research disclosure website, www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
Questions and Answers:
Joseph Modisett -So Welcome, Jeff. You've been quite busy here over since the IPO. And I thought maybe it's just as we start, obviously, there's been a lot of changes to your business. Obviously, you stood up the business coming out of Lilly. You've done a number of major strategic deals, Bayer being the most -- the largest and probably the most important. A lot of operational changes, whether it be channel strategy or productivity
Trustpilot
